251–300 of 20,598 genesranked by Most Researched

#	Gene	Name	Chr	Tags	PubMed Papers
251	MMP3	matrix metallopeptidase 3	11	ProteaseClinical Trials	792
252	CBL	Cbl proto-oncogene	11	OncogeneOMIM Disease Gene	785
253	ALB	albumin	4	OMIM Disease GeneHighly Studied	784
254	LPL	lipoprotein lipase	8	OMIM Disease GeneHighly Studied	784
255	BCL2L1	BCL2 like 1	20	Highly ConstrainedFDA Approved Target	780
256	CXCL10	C-X-C motif chemokine ligand 10	4	Clinical TrialsHighly Studied	776
257	GJA1	gap junction protein alpha 1	6	OMIM Disease GeneHighly Studied	773
258	PCSK9	proprotein convertase subtilisin/kexin type 9	1	ProteaseFDA Approved Target	771
259	TIMP1	TIMP metallopeptidase inhibitor 1	X	Highly StudiedExperimental GO Evidence	770
260	BSG	basigin (Ok blood group)	19	ReceptorClinical Trials	769
261	CYP3A5	cytochrome P450 family 3 subfamily A member 5	7	FDA Approved TargetHighly Studied	763
262	SERPINA1	serpin family A member 1	14	OMIM Disease GeneHighly Studied	763
263	YBX1	Y-box binding protein 1	1	Highly ConstrainedHighly Studied	763
264	SMARCA4	SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4	19	Highly ConstrainedOMIM Disease Gene	762
265	FGFR1	fibroblast growth factor receptor 1	8	Highly ConstrainedKinase	760
266	WT1	WT1 transcription factor	11	Highly ConstrainedTranscription Factor	759
267	CREB1	cAMP responsive element binding protein 1	2	Highly ConstrainedTranscription Factor	757
268	ERCC1	ERCC excision repair 1, endonuclease non-catalytic subunit	19	DNA RepairOMIM Disease Gene	757
269	FUS	FUS RNA binding protein	16	Highly ConstrainedOncogene	757
270	IGFBP3	insulin like growth factor binding protein 3	7	Highly StudiedExperimental GO Evidence	757
271	C3	complement C3	19	FDA Approved TargetOMIM Disease Gene	756
272	TLR3	toll like receptor 3	4	ReceptorClinical Trials	750
273	UGT1A1	UDP glucuronosyltransferase family 1 member A1	2	OMIM Disease GeneHighly Studied	750
274	INSR	insulin receptor	19	KinaseReceptor	749
275	IGF2	insulin like growth factor 2	11	Clinical TrialsOMIM Disease Gene	748
276	TWIST1	twist family bHLH transcription factor 1	7	OMIM Disease GeneHighly Studied	747
277	LEPR	leptin receptor	1	ReceptorFDA Approved Target	746
278	APEX1	apurinic/apyrimidinic endodeoxyribonuclease 1	14	DNA RepairHighly Studied	744
279	NAT2	N-acetyltransferase 2	8	Highly StudiedExperimental GO Evidence	744
280	MECP2	methyl-CpG binding protein 2	X	Highly ConstrainedOMIM Disease Gene	740
281	XRCC6	X-ray repair cross complementing 6	22	DNA RepairHighly Constrained	740
282	HSPD1	heat shock protein family D (Hsp60) member 1	2	Highly ConstrainedOMIM Disease Gene	739
283	IL13	interleukin 13	5	FDA Approved TargetOMIM Disease Gene	739
284	BMP2	bone morphogenetic protein 2	20	Highly ConstrainedOMIM Disease Gene	738
285	PRKACA	protein kinase cAMP-activated catalytic subunit alpha	19	Highly ConstrainedKinase	737
286	HTR2A	5-hydroxytryptamine receptor 2A	13	ReceptorFDA Approved Target	736
287	RBX1	ring-box 1	22	DNA RepairFDA Approved Target	734
288	SCN5A	sodium voltage-gated channel alpha subunit 5	3	Ion ChannelTransporter	732
289	SMAD2	SMAD family member 2	18	Highly ConstrainedTranscription Factor	732
290	IL33	interleukin 33	9	Clinical TrialsHighly Studied	730
291	TNFSF11	TNF superfamily member 11	13	ReceptorFDA Approved Target	722
292	DRD4	dopamine receptor D4	11	ReceptorHighly Studied	720
293	KMT2A	lysine methyltransferase 2A	11	Highly ConstrainedOncogene	720
294	PRKCD	protein kinase C delta	3	ApoptosisHighly Constrained	720
295	NFKBIA	NFKB inhibitor alpha	14	OMIM Disease GeneHighly Studied	719
296	BECN1	beclin 1	17	Highly ConstrainedHighly Studied	716
297	CDK4	cyclin dependent kinase 4	12	KinaseFDA Approved Target	714
298	FGFR2	fibroblast growth factor receptor 2	10	Highly ConstrainedKinase	713
299	CALR	calreticulin	19	Highly StudiedExperimental GO Evidence	712
300	FLNA	filamin A	X	Highly ConstrainedClinical Trials	712